BSc in Biology, Yale University. Over 10 years' experience in healthcare investing, focused primarily on biotechnology companies. 2006, co-founded 23andMe, saw need for creating way to generate more information, especially more personalized information, so that commercial and academic researchers could better understand and develop new drugs and diagnostics.